NABP DMEPOS Pharmacy Accreditation vs. Other CMS-Approved Accreditors
Comparing NABP, The Joint Commission, ACHC, and BOC for DMEPOS Pharmacy Accreditation
Pharmacies seeking DMEPOS accreditation have a choice among several CMS-approved accrediting organizations. This comparison helps pharmacies understand the differences between NABP and the other major options so they can select the accrediting body best suited to their operations.
Note: All organizations listed below are CMS-approved for DMEPOS supplier accreditation. CMS approval means each organization's accreditation satisfies the federal Medicare billing requirement equally. The differences are in scope, process, focus, and fit for pharmacy operations specifically.
Side-by-Side Comparison
| Dimension | NABP DMEPOS Pharmacy | The Joint Commission | ACHC (Accreditation Commission for Health Care) | Board of Certification/Accreditation (BOC) |
|---|---|---|---|---|
| CMS-approved | Yes | Yes | Yes | Yes |
| Pharmacy-specific focus | Yes — designed specifically for pharmacies | No — generalist healthcare accreditor | Partial — covers both pharmacies and non-pharmacy DMEPOS suppliers | No — focuses on orthotics/prosthetics practitioners primarily |
| Accreditation term (2026) | 1 year (changed from 3-year per CMS final rule) | 3 years | 3 years | 3 years |
| On-site inspection required | Application-based review; site inspection where required | Yes — on-site survey | Yes — on-site survey | Yes — on-site survey |
| Standards aligned with pharmacy practice | Yes — NABP is the national pharmacy regulatory body | Partial | Partial | Limited — O&P practitioner focus |
| Best fit for | Independent retail pharmacies, mail-order pharmacies, specialty pharmacies | Large health systems, hospital outpatient pharmacies | Independent HME/DMEPOS companies, home health agencies, pharmacies | Orthotics and prosthetics practitioners |
| Ongoing compliance monitoring | Annual compliance review (now required each year) | Mid-cycle focused review | Annual self-assessment | Annual report |
Why Many Pharmacies Choose NABP for DMEPOS Accreditation
NABP is the national association of state boards of pharmacy — the same organization that administers pharmacist licensing, the NAPLEX, and the MPJE. Its DMEPOS Pharmacy Accreditation program was designed specifically for the pharmacy operating model, meaning the standards, terminology, and review process are calibrated to how pharmacies actually operate rather than adapted from a generalist healthcare framework.
For independent retail pharmacies — the largest segment of DMEPOS pharmacy accreditation applicants — NABP's pharmacy-centric approach typically results in a more straightforward documentation process than working with accreditors whose standards are primarily designed for non-pharmacy DMEPOS suppliers. NABP staff understand pharmacy law and practice and can respond meaningfully to pharmacy-specific questions during the application process.
When Another CMS-Approved Accreditor May Be Appropriate
NABP is not always the best fit. Considerations that may favor a different accreditor include:
- Large health system pharmacies that are already under Joint Commission accreditation for their hospital operations may find it more efficient to extend their TJC accreditation relationship to include DMEPOS rather than managing a separate NABP accreditation
- Pharmacies co-located with HME/DMEPOS companies that already hold ACHC accreditation may benefit from a unified ACHC accreditation structure across both the pharmacy and HME operations
- Pharmacies with significant orthotics/prosthetics business may need BOC credentialing for their O&P practitioners regardless of their choice of DMEPOS accreditor
IHS evaluates your specific organizational structure, existing accreditation relationships, and operational profile to recommend the right accreditor for your situation — not just the one we are most familiar with.
The Annual vs. 3-Year Term Difference
One significant practical difference between NABP and most other CMS-approved DMEPOS accreditors as of 2026: NABP DMEPOS Pharmacy Accreditation now operates on a 1-year term per CMS's final rule, while The Joint Commission, ACHC, and BOC continue to offer 3-year accreditation cycles. For pharmacies that prioritize minimizing the administrative burden of ongoing accreditation maintenance, this is a material consideration. IHS advises clients on how to evaluate this tradeoff in the context of their specific operational capacity.
Not Sure Which DMEPOS Accreditor Is Right for Your Pharmacy?
IHS provides accreditor-neutral advisory on the right DMEPOS accreditation strategy for your pharmacy. Thomas G. Goddard, JD, PhD — former Chief Operating Officer and General Counsel of URAC — has experience across all major accrediting organizations.
Schedule a Free Discovery Session